High density lipoprotein subfractions: Isolation, composition, and their duplicitous role in oxidation

Journal of Lipid Research

Volumn 48, Issue 1, 2007, Pages 86-95

  McPherson, Peter A C ^a   Young, Ian S ^a   McKibben, Bronac ^a   McEneny, Jane ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Apolipoproteins; Cholesteryl ester transfer protein; Lecithin:cholesterol acyltransferase; Lipid hydroperoxides; Single radial immunodiffusion; Transferrin; Ultracentrifugation

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; HYDROPEROXIDE DERIVATIVE; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; TRANSFERRIN; VERY LOW DENSITY LIPOPROTEIN;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; FRACTIONATION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; ULTRACENTRIFUGATION;

ANTIOXIDANTS; CHOLESTEROL; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; OXIDATION-REDUCTION; PHOSPHOLIPIDS; REFERENCE VALUES; TRIGLYCERIDES;

EID: 33845986686     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600094-JLR200     Document Type: Article

References (50)

1. Fielding, C. J., and P. E. Fielding. 1995. Molecular physiology of the reverse cholesterol transport. J. Lipid Res. 36: 211-218.
2. 3 cholesterol concentrations. Clin. Chem. 34: 2322-2327.
3. 3 in a random population of healthy French males and females - evaluation by a two-step precipitation procedure. Clin. Chim. Acta. 189: 111-122.
4. 3 determined in serum by discontinuous gradient gel electrophoresis. Clin. Chem. 37: 1149-1152.
5. Hidaka, H., M. Tozuka, B. Meyer, K. Yamauchi, M. Sugano, T. Nakabayashi, and T. Katsuyama. 2003. Characterisation of triglyceride rich lipoproteins with very light density by ultracentrifugation and agarose gel electrophoresis using triglyceride- and cholesterolstaining. Ann. Clin. Lab. Sci. 33: 167-178.
6. Weisgraber, K. H., and R. W. Mahley. 1980. Subfractionation of human high density lipoproteins by heparin-Sepharose affinity chromatography. J. Lipid Res. 21: 316-325.
7. Cheung, M. C., and J. J. Alberts. 1979. Distribution of cholesterol and apolipoprotein A-I and A-II in human high density lipoprotein subfractions separated by CsCl equilibrium gradient centrifugation: evidence for HDL subpopulations with differing A-I/A-II molar ratios. J. Lipid Res. 20: 200-207.
8. 1 by zonal ultracentrifugation. J. Lipid Res. 23: 903-910.
9. Chung, B., T. Wilkinson, J. Geer, and J. Segrest. 1980. Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. J. Lipid Res. 21: 284-291.
10. Chapman, M., S. Goldstein, D. Lagrange, and M. Laplaud. 1981. A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J. Lipid Res. 22:339-358.
11. Patsch, W., G. Schonfeld, A. Gotto, and J. Patsch. 1980. Characterisation of human high density lipoproteins by zonal ultracentrifugation. J. Biol. Chem. 255: 3178-3185.
12. Brousseau, T., V. Clavey, J. Bard, and J. Fruchart. 1993. Sequential ultracentrifugation micromethod for separation of serum lipoproteins and assays of lipids, apolipoproteins, and lipoprotein particles. Clin. Chem. 39: 960-964.
13. DeLalla, O., and J. Gofman. 1954. Ultracentrifugal analysis of serum lipoproteins. Methods of Biochemical Analysis. 1: 459-478.
14. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
15. Kunitake, S., and J. Kane. 1982. Factors affecting the integrity of high density lipoproteins in the ultracentrifuge. J. Lipid Res. 23:936-940.
16. Pietzsch, J., S. Subat, S. Nitzsche, W. Leonhardt, K. Schentke, and M. Hanefeld. 1995. Very fast ultracentrifugation of serum lipoproteins: influence on lipoprotein separation and composition. Biochim. Biophys. Acta. 1254: 77-88.
17. Stein, O., and Y. Stein. 1999. Atheroprotective mechanisms of HDL. Atherosclerosis. 144: 285-301.
18. Garner, B., A. R. Waldeck, P. K. Witting, K-A. Rye, and R. Stocker. 1998. Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII. J. Biol. Chem. 273: 6088-6095.
19. Bergmeier, C., R. Siekmeier, and W. Gross. 2004. Distribution spectrum of paraoxonase activity in HDL fractions. Clin. Chem. 50:2309-2315.
20. Mackness, B., and M. Mackness. 2004. Paraoxonase-1: biochemistry and contribution to atherosclerosis. Int. Congr. Ser. 1262: 91-94.
21. Kunitake, S. T., M. R. Jarvis, R. L. Hamilton, and J. P. Kane. 1992. Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins. Proc. Natl. Acad. Sci. USA. 89: 6993-6997.
22. Blankenberg, S., S. Barbaux, and L. Tiret. 2003. Adhesion molecules and atherosclerosis. Atherosclerosis. 170: 191-203.
23. Marui, N., M. K. Offermann, R. Swerlick, C. Sunsch, C. A. Rosen, M. Ahmad, R. W. Alexander, and R. M. Medford. 1993. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 92: 1866-1874.
24. Cockerill, G. W., J. Saklatvala, S. H. Ridley, H. Yarwood, N. E. Miller, B. Oral, S. Nithyanathan, G. Taylor, and D. O. Haskard. 1999. High-density lipoproteins differentially modulate cytokine-induced expression of E-selectin and cyclooxygenase-2. Arterioscler. Thromb. Vasc. Biol. 19: 910-917.
25. Park, S., J. H. Y. Park, J. Kang, and Y. Kang. 2003. Involvement of transcription factors in plasma HDL protection against TNF-a induced vascular cell adhesion molecule-1 expression. Int. J. Biochem. Cell Biol. 35: 168-182.
26. Chung, B. H., J. P. Sergrest, M. J. Ray, J. D. Brunzell, J. E. Hokanson, R. M. Krauss, K. Beaudrie, and J. T. Cone. 1986. Single vertical spin density gradient ultracentrifugation. Methods Enzymol. 128: 181-209.
27. Radding, C. M., and D. Steinberg. 1960. Studies on the synthesis and secretion of serum lipoproteins by rat liver slices. J. Clin. Invest. 39: 1560-1569.
28. McEneny, J., C. M. Loughery, P. T. McNamee, E. R. Trimble, and I. S. Young. 1997. Susceptibility of VLDL to oxidation in patients on regular haemodialysis. Atherosclerosis. 129: 215-220.
29. McDowell, I. F. W., J. McEneny, and E. R. Trimble. 1995. A rapid method for measurement of the susceptibility to oxidation of low density lipoprotein. Ann. Clin. Biochem. 32: 167-174.
30. Mancini, G., A. O. Carbonara, and J. F. Heremans. 1965. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 2: 235-254.
31. Becker, W. 1969. Determination of antisera titres using the single radial immunodiffusion method. Immunochemistry. 6: 539-546.
32. McDowell, I. F., G. B. Wisdom, and E. R. Trimble. 1989. Apolipoprotein E phenotype determined by agarose gel electrofocusing and immunoblotting. Clin. Chem. 35: 2070-2073.
33. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227: 680-685.
34. Wolff, S. P. 1994. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Methods Enzymol. 233: 182-189.
35. Naurooz-Zadeh, J., J. Tajaddini-Sarmadi, and S. P. Wolff. 1994. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal. Biochem. 220: 403-409.
36. Connolly, D. T., D. Hauvelman, and K. Glenn. 1996. Inactivation of cholesteryl ester transfer protein by cysteine modification. Biochem. Biophys. Res. Commun. 223: 42-47.
37. Holmquist, L. 2002. Selective extraction of lecithin:cholesterol acyltransferase (EC 2.3.1.43) from human plasma. J. Biochem. Biophys. Methods. 52: 63-68.
38. Miller, J. P., S. J. T. Mao, J. R. Patsch, and A. M. Gotto. 1980. The measurement of apolipoprotein A-I in human plasma by electroimmunoassay. J. Lipid Res. 21: 775-780.
39. Alberts, J. J., M. C. Cheung, and P. W. Wahl. 1980. Effect of storage on the measurement of apolipoproteins A-I and A-II by radial immunodiffusion. J. Lipid Res. 21: 874-878.
40. Vohl, M., T. A-M. Neville, R. Kumarathasan, S. Braschi, and D. L. Sparks. 1999. A novel lecithin-cholesterol acyltransferase antioxidant activity prevents the formation of oxidized lipids during lipoprotein oxidation. Biochemistry. 38: 5976-5981.
41. Eisenberg, S. 1984. High density lipoprotein metabolism. J. Lipid Res. 25: 1017-1058.
42. nd edition. Butterworth-Heinemann, Oxford, UK.
43. rd edition. W. B. Saunders, Philadelphia, PA.
44. Ramos, P., S. P. Gieseg, B. Schuster, and H. Esterbauer. 1995. Effect of temperature and phase transition on oxidation resistance of low density lipoprotein. J. Lipid Res. 36: 2113-2128.
45. Ziouzenkova, O., A. Sevanian, P. M. Abuja, P. Ramos, and H. Esterbauer. 1998. Copper can promote oxidation of LDL by markedly different mechanisms. Free Radic. Biol. Med. 24: 607-623.
46. Maxwell, S. R. J., and G. Y. H. Lip. 1997. Free radicals and antioxidants in cardiovascular disease. Br. J. Clin. Pharmacol. 44: 307-317.
47. Bowry, V. W., K. K. Stanley, and R. Stocker. 1992. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc. Natl. Acad. Sci. USA. 89:10316-10320.
48. Hirano, K., S. Yamashita, Y. Kuga, N. Sakai, S. Nozaki, S. Kihara, T. Arai, K. Yanagi, S. Takami, M. Menju, et al. 1995. Atherosclerotic disease in marked hyperalphalipoproteinaemia. Arterioscler. Thromb. Vasc. Biol. 15: 1849-1856.
49. Zhong, S., D. S. Sharp, J. S. Grove, C. Bruce, K. Yano, J. D. Curb, and A. R. Tall. 1996. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J. Clin. Invest. 97:2917-2923.
50. Alarcon, S. B. K., H. C. F. Oliveira, L. M. Harada, V. S. Nunes, D. Kaplan, E. C. R. Quintão, and E. C. de Faria. 2004. Moderate hyperalphalipoproteinaemia in a Brazilian population is related to lipoprotein lipase activity, apolipoprotein A-I concentration, age and body mass index. Clin. Sci. 106: 11-17.